Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/234458
Title: Does initial routine use of a compression garment reduce the risk of lower limb lymphedema after gynecological cancer treatment? A randomized pilot study in an asian institution and review of the literature
Authors: Hnin, YK
Ong, LX
Tsai, CCC
Ong, SS
Yee, SG
Choo, BA
Low, JJH 
Keywords: compression garments
gynecologic cancer
lower limb lymphedema
perometry
Adult
Aged
Case-Control Studies
Compression Bandages
Female
Follow-Up Studies
Genital Neoplasms, Female
Humans
Lymph Node Excision
Lymphedema
Middle Aged
Pilot Projects
Prognosis
Young Adult
Issue Date: 1-Jan-2018
Citation: Hnin, YK, Ong, LX, Tsai, CCC, Ong, SS, Yee, SG, Choo, BA, Low, JJH (2018-01-01). Does initial routine use of a compression garment reduce the risk of lower limb lymphedema after gynecological cancer treatment? A randomized pilot study in an asian institution and review of the literature. Lymphology 51 (4) : 174-183. ScholarBank@NUS Repository.
Abstract: This is a randomized pilot study evaluating the effectiveness of customized compression garments (CG) in reducing the risk of lower limb lymphedema (LLL) in gynecological cancer patients. Patients who completed pelvic node dissection or radiation were routinely educated on reducing the risk of LLL by good skin care and manual lymphatic massage. After baseline lower limb volume perometry and clinical assessment, they were randomized to customized compression garment (CG) for 6 weeks (26 patients) or observation (30 patients). Both groups were followed up for 2 years and the primary outcome was the development of LLL. LLL incidence in the control group was 13.3% (4 of 30 patients) compared to 7.7% (2 of 26 patients) in the CG group. However the difference was not statistically significant (P=0.496). In the control group, 10.7% (3/28) who underwent node dissection developed LLL vs 7.7% (2/26) in the CG group. Among patients with node dissection plus radiation, LLL incidence was 14.3% (1/7) in the control group vs 12.5% (1/8) in the CG group. The mean onset of LLL was 12 months; compliance to CG wearing was high and QOL scores were similar in both groups. Customized low-compression CG worn for 6 weeks may have a possible benefit in reducing the risk of LLL when added to patient education on risk reduction although statistic significance was not achieved in this small pilot study. A larger multi-center study would be justified to expand these findings.
Source Title: Lymphology
URI: https://scholarbank.nus.edu.sg/handle/10635/234458
ISSN: 0024-7766
2522-7963
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
23202-44187-1-PB.pdfPublished version310.23 kBAdobe PDF

CLOSED

Published

Page view(s)

18
checked on Feb 2, 2023

Download(s)

1
checked on Feb 2, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.